Funding for this research was provided by:
Elanco Animal Health
Text and Data Mining valid from 2018-07-13
Received: 13 February 2018
Accepted: 21 June 2018
First Online: 13 July 2018
Ethics approval and consent to participate
: This clinical field study was conducted in compliance with local and national regulatory requirements in France and Spain and consistent with the principles of Good Clinical Practices the VICH guideline on good clinical practice (GCP; VICH GL 9) and Directive 2001/82/EC as amended; the Rules Governing Medicinal Products in the European Union, Volume VIIA: Guidelines for the testing of veterinary medicinal products: Demonstration of Efficacy of Ectoparasiticides, 7AE17a, page 215–222; EMEA/CVMP/EWP/ 005/2000-Rev.2: Guideline for the testing and evaluation of the efficacy of antiparasitic substances for the treatment and prevention of flea and flea infestation in dogs and cats, 12 Nov 2007; and with the guidelines of the World Association for the Advancement of Veterinary Parasitology. Participating cat owners were required to sign an informed consent form for their cat(s) to participate in the study after details of the study design and products under investigation had been explained.
: Not applicable.
: DC, WS, MM and SN are employees of Elanco Animal Health.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.